PMID- 32812475 OWN - NLM STAT- MEDLINE DCOM- 20211122 LR - 20211122 IS - 1744-8301 (Electronic) IS - 1479-6694 (Linking) VI - 16 IP - 33 DP - 2020 Nov TI - Dysregulated microRNAs in laryngeal cancer: a comprehensive meta-analysis using a robust rank aggregation approach. PG - 2723-2734 LID - 10.2217/fon-2020-0394 [doi] AB - We need a reasonable method of compiling data from different studies regarding the expression of microRNA (miRNA) in laryngeal squamous cell carcinoma (LSCC). The robust rank aggregation method was used to integrate the rank lists of miRNAs from 11 studies. The enrichment analysis was performed on target genes of meta-signature miRNAs. The Cancer Genome Atlas database was used to confirm the results of meta-analysis. Three meta-signature miRNAs (miR-21-5p, miR-196a-5p and miR-145-5p) were obtained. All three miRNAs could be prognostic for LSCC. The enrichment analysis showed that these miRNAs were associated significantly with multiple cancer-related signaling pathways. The robust rank aggregation approach is an effective way to identify important miRNAs from different studies. All identified miRNAs could be candidates for LSCC diagnostic and prognostic biomarkers. FAU - Cao, Zaizai AU - Cao Z AD - Zhejiang University, Zhejiang Province, 310003, PR China. AD - Department of Otolaryngology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang Province, 310003, PR China. FAU - Guo, Yu AU - Guo Y AD - Zhejiang University, Zhejiang Province, 310003, PR China. AD - Department of Otolaryngology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang Province, 310003, PR China. FAU - Ao, Yinjie AU - Ao Y AD - Zhejiang University, Zhejiang Province, 310003, PR China. AD - Department of Otolaryngology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang Province, 310003, PR China. FAU - Zhou, Shuihong AU - Zhou S AUID- ORCID: 0000-0002-7163-2289 AD - Zhejiang University, Zhejiang Province, 310003, PR China. AD - Department of Otolaryngology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang Province, 310003, PR China. LA - eng PT - Journal Article PT - Meta-Analysis DEP - 20200819 PL - England TA - Future Oncol JT - Future oncology (London, England) JID - 101256629 RN - 0 (Biomarkers, Tumor) RN - 0 (MicroRNAs) SB - IM MH - Biomarkers, Tumor MH - Computational Biology/methods MH - Gene Expression Profiling MH - *Gene Expression Regulation, Neoplastic MH - Humans MH - Laryngeal Neoplasms/diagnosis/*genetics/metabolism/mortality MH - MicroRNAs/*genetics MH - Prognosis MH - Signal Transduction MH - Squamous Cell Carcinoma of Head and Neck/genetics OTO - NOTNLM OT - gene oncology OT - laryngeal squamous cell cancer OT - miRNA OT - prognosis OT - robust rank aggregation EDAT- 2020/08/20 06:00 MHDA- 2021/11/23 06:00 CRDT- 2020/08/20 06:00 PHST- 2020/08/20 06:00 [pubmed] PHST- 2021/11/23 06:00 [medline] PHST- 2020/08/20 06:00 [entrez] AID - 10.2217/fon-2020-0394 [doi] PST - ppublish SO - Future Oncol. 2020 Nov;16(33):2723-2734. doi: 10.2217/fon-2020-0394. Epub 2020 Aug 19.